Volume 25, Number 12—December 2019
Research
Cost-effectiveness of Prophylactic Zika Virus Vaccine in the Americas
Figure 1

Figure 1. Range of vaccination costs per individual (VCPI; in 2015 US dollars) for the scenarios of whether Zika virus vaccines would be cost-saving (green), very cost-effective (red), and cost-effective (black). All estimates are based on the level of preexisting herd immunity in the population for each country.